PubMed:24691501 / 1474-1636 JSONTXT

{"project":"c_corpus","denotations":[{"id":"T215","span":{"begin":17,"end":24},"obj":"C552206"},{"id":"T216","span":{"begin":17,"end":24},"obj":"C552206"},{"id":"T219","span":{"begin":47,"end":51},"obj":"SO:0000234"},{"id":"T217","span":{"begin":47,"end":51},"obj":"D012333"},{"id":"T218","span":{"begin":47,"end":51},"obj":"CHEBI:33699"},{"id":"T220","span":{"begin":62,"end":68},"obj":"UBERON:0027368"},{"id":"T221","span":{"begin":62,"end":87},"obj":"D020782"},{"id":"T223","span":{"begin":151,"end":161},"obj":"SO:1000009"}],"text":"In addition, the BXL0124 treatment reduced the mRNA levels of matrix metalloproteinases starting at week 3, contributing to the inhibition of invasive transition."}

{"project":"UseCases_ArguminSci_Discourse","denotations":[{"id":"T12","span":{"begin":0,"end":162},"obj":"DRI_Approach"}],"text":"In addition, the BXL0124 treatment reduced the mRNA levels of matrix metalloproteinases starting at week 3, contributing to the inhibition of invasive transition."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T10","span":{"begin":0,"end":162},"obj":"DRI_Approach"}],"text":"In addition, the BXL0124 treatment reduced the mRNA levels of matrix metalloproteinases starting at week 3, contributing to the inhibition of invasive transition."}